We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AACC Middle East 2023 to Explore Latest Trends in Clinical Pathology and Laboratory Medicine

By LabMedica International staff writers
Posted on 29 Sep 2023
Print article
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)

The AACC Middle East Conference and Exposition will be held by the Association for Diagnostics & Laboratory Medicine (ADLM - formerly AACC, Washington, DC, USA) in partnership with Life Dx (Abu Dhabi, UAE) on October 7-8, 2023, at the Grand Hyatt Hotel in Dubai, UAE. At AACC Middle East 2023, attendees will have the chance to engage with industry leaders, healthcare experts, and academics in the field of clinical pathology and laboratory medicine. The exhibit area will attract over 1,000 attendees and feature leading companies in the In Vitro Diagnostics (IVD) sector.

The two-day conference will focus on emerging topics particularly relevant to the Middle East region, while the exposition will showcase the most recent advancements in various aspects such as mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing, point-of-care technologies, and automation. The conference agenda includes educational programs and a dynamic exposition, featuring the newest trends in clinical lab medicine, diagnostics, and best practices from experts. Topics to be discussed range from infectious diseases and big data analytics to prenatal emerging technologies, along with core laboratory practices like sample transportation, lab management, and quality assurance. Each session will feature knowledgeable speakers from AACC's scientific leadership. The event offers a unique opportunity for attendees to network with peers and experts, both from the United States and the Middle East, to exchange insights on the latest in laboratory medicine.

AACC Middle East is tailored for a diverse audience including physicians, lab supervisors, lab directors and their assistants, lab managers, medical technologists, pathologists, immunologists, fellows, residents, and those in training, among other healthcare professionals with an interest in laboratory medicine. Participants will have the chance to explore the latest research and technologies in the field. They can also gain insights into effective lab management strategies to streamline workflows, improve testing accuracy, and subsequently enhance treatment decisions and patient outcomes. Moreover, attendees will also learn how to adopt modern lab testing methods and technology, along with data-driven practices for preanalytical, analytical, and postanalytical phases of sample processing.

Related Links:
ADLM 
Life Dx 

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.